Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Data Collection × Thoracic × 1 year × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Tumor-Agnostic 6 Gastrointestinal 3 Other hematologic neoplasm 2 NET 2 Lymphoid 2 Genitourinary 2 Endocrine 2 Thoracic 1 Sarcoma 1 Other solid neoplasm 1 Head & Neck 1 Gynecologic 1 Dermatologic 1 Breast 1

Conditions

Mesothelioma, Malignant 1 Mesothelioma 1

Interventions

Carboplatin 321 pembrolizumab 302 Pemetrexed 230 Cisplatin 196 Paclitaxel 139 durvalumab 131 Nivolumab 123 osimertinib 96 Docetaxel 94 atezolizumab 92 Specimen Handling 80 Drug Therapy 79 Radiotherapy 70 Magnetic Resonance Spectroscopy 70 Etoposide 64 Gemcitabine 60 Radiosurgery 57 Ipilimumab 47 Bevacizumab 47 tislelizumab 45 130-nm albumin-bound paclitaxel 44 cemiplimab 40 Blood Specimen Collection 35 Biopsy 30 Taxes 29 Standard of Care 29 Platinum 28 Immunotherapy 28 Immune Checkpoint Inhibitors 28 Cetuximab 28

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05308966 2025-10-06

MESO-IMMUNE

Groupe Francais De Pneumo-Cancerologie

Other solid neoplasmThoracic

Mesothelioma, Malignant, Mesothelioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡